Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AZ › Sun City › NPI 1952560914
Clinic

Banner Boswell Medical Center

Banner Boswell Medical Center was paid $27.10M by Medicaid between Jan 2018 and Dec 2024, across 264 billing codes. Its largest line is 99285, emergency room visit (most serious) — 34% of everything it billed.

33Billing provider infoBANNER BOSWELL MEDICAL CENTER
SUN CITY, AZ 85351
33aNPI1952560914assigned 06/05/2008
33bProvider typeRehabilitation Clinic/Center
28Total paid$27.10M
24GClaims1,100,467
24DCodes billed264
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rehabilitation Clinic/Center providers in Arizona

Rank by total paid#1 of 40
Median peer was paid$161K
This provider vs. median169×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018175,265$4.04M
2019148,775$3.86M
2020118,301$3.32M
2021154,771$3.85M
2022169,513$3.99M
2023180,199$4.08M
2024incomplete153,643$3.96M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 34% 27,736 24,074 $9.21M
74177 Computed tomography, abdomen and pelvis; with contrast material 18% 9,082 8,362 $4.98M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 26,735 24,257 $4.34M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 15,824 14,707 $2.82M
70450 Computed tomography, head or brain; without contrast material 3.8% 11,696 10,469 $1.02M
74176 Computed tomography, abdomen and pelvis; without contrast material 2.8% 4,200 3,766 $746K
G0378 Hospital observation service, per hour 2.3% 22,585 11,475 $635K
72125 Computed tomography, cervical spine; without contrast material 1.7% 3,341 3,008 $473K
49083 1.4% 887 385 $375K
71275 Computed tomographic angiography, chest, with contrast material 1.4% 3,744 3,499 $367K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.3% 3,623 3,408 $348K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 220 211 $199K
252 more codes
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 121 $172K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 697 $143K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 918 $128K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,345 $123K
C1769 Guide wire <1% 2,260 $86K
80053 Comprehensive metabolic panel <1% 57,232 $80K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 4,760 $73K
93971 <1% 1,914 $69K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 9,012 $46K
93970 <1% 214 $40K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 31,195 $34K
71250 <1% 784 $34K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 3,125 $33K
36430 <1% 176 $32K
96361 Intravenous infusion, hydration; each additional hour <1% 5,875 $30K
93458 <1% 26 $28K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,017 $28K
74174 <1% 43 $27K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 70 $26K
70551 Magnetic resonance imaging, brain; without contrast material <1% 505 $24K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 573 $24K
71046 Radiologic examination, chest; 2 views <1% 3,212 $22K
70496 <1% 48 $22K
96375 Therapeutic injection; each additional sequential IV push <1% 22,870 $19K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 15 $16K
70486 <1% 622 $15K
80320 <1% 5,055 $14K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,718 $12K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 25,538 $12K
96376 <1% 11,166 $11K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,731 $10K
88341 <1% 125 $10K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 374 $10K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 181 $8K
72131 <1% 29 $7K
80048 Basic metabolic panel (calcium, ionized) <1% 12,776 $7K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 185 $6K
71045 Radiologic examination, chest; single view <1% 25,140 $5K
75574 <1% 44 $5K
70491 <1% 12 $5K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 60,494 $5K
J8597 Antiemetic drug, oral, not otherwise specified <1% 2,255 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 6,849 $4K
86850 <1% 3,321 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 9,747 $3K
J3490 Unclassified drugs <1% 29,588 $3K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 696 $3K
87631 <1% 2,572 $3K
J1756 Injection, iron sucrose, 1 mg <1% 30 $3K
82728 <1% 363 $3K
72100 <1% 2,067 $3K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 5,750 $3K
84484 <1% 29,248 $2K
86920 <1% 19 $2K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,792 $2K
83690 <1% 18,130 $2K
84443 Thyroid stimulating hormone (TSH) <1% 5,030 $1K
73630 <1% 1,702 $1K
73562 <1% 2,133 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 474 $1K
83880 <1% 6,640 $1K
99213 Doctor's office visit, returning patient (routine) <1% 98 $1K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 16,611 $1K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,997 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 22,997 $1K
86923 <1% 111 $1K
81025 <1% 7,734 $977.63
85610 <1% 27,794 $958.70
73610 <1% 1,214 $947.82
83735 <1% 25,397 $905.52
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,865 $850.69
87086 Culture, bacterial; quantitative colony count, urine <1% 8,112 $834.24
74018 <1% 414 $824.00
73030 <1% 1,845 $808.36
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 610 $797.70
73130 <1% 1,040 $787.99
87040 <1% 7,173 $709.67
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 134 $706.20
81001 <1% 16,109 $684.32
83605 <1% 11,217 $669.47
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,326 $661.55
73502 <1% 1,024 $626.72
97535 Self-care/home management training, each 15 minutes <1% 377 $618.46
84703 <1% 6,443 $607.78
76830 Ultrasound, transvaginal <1% 512 $545.20
84702 <1% 1,629 $507.17
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 854 $462.48
36591 <1% 780 $460.23
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 139 $450.01
97116 <1% 1,535 $444.64
J2270 Injection, morphine sulfate, up to 10 mg <1% 12,260 $442.75
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 855 $442.07
90715 <1% 1,333 $440.79
93880 <1% 32 $429.65
82947 <1% 22,808 $420.61
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,016 $364.50
85730 <1% 931 $351.44
J7030 Infusion, normal saline solution , 1000 cc <1% 13,628 $318.35
85379 <1% 1,253 $311.17
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 412 $298.51
70498 <1% 47 $294.43
97161 <1% 2,765 $288.65
93976 <1% 208 $281.76
82550 <1% 8,296 $267.33
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 11,823 $259.11
87088 <1% 6,142 $258.36
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,724 $252.79
88342 <1% 700 $241.88
85027 <1% 9,050 $226.59
77067 Screening mammography, bilateral, including computer-aided detection <1% 16 $225.74
73110 <1% 619 $211.24
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 14 $200.04
82803 <1% 146 $185.07
C9113 Injection, pantoprazole sodium, per vial <1% 2,696 $172.50
82565 <1% 2,392 $158.51
81003 <1% 8,884 $149.31
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,687 $147.67
85055 <1% 1,613 $146.18
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 378 $131.57
J0690 Injection, cefazolin sodium, 500 mg <1% 4,051 $128.47
96367 <1% 848 $126.88
86901 <1% 3,660 $120.00
86900 <1% 3,458 $115.04
73080 <1% 143 $113.31
J2704 Injection, propofol, 10 mg <1% 8,753 $110.49
80061 Lipid panel <1% 1,858 $108.93
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,497 $105.14
73590 <1% 128 $97.98
87186 <1% 2,736 $94.50
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility <1% 16 $94.04
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 33,725 $91.66
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,687 $89.04
J3010 Injection, fentanyl citrate, 0.1 mg <1% 11,920 $87.89
84145 <1% 690 $84.96
87077 <1% 3,205 $75.71
J0360 Injection, hydralazine hcl, up to 20 mg <1% 1,331 $67.37
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,715 $59.73
83036 Hemoglobin; glycosylated (A1C) <1% 2,066 $54.22
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,225 $53.39
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 17 $51.31
93017 <1% 30 $49.97
J2060 Injection, lorazepam, 2 mg <1% 3,066 $49.47
J1170 Injection, hydromorphone, up to 4 mg <1% 3,265 $48.72
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,553 $46.07
84439 <1% 492 $45.40
86140 <1% 1,613 $45.24
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,372 $44.90
J1815 Injection, insulin, per 5 units <1% 6,526 $44.56
51702 <1% 33 $44.54
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,892 $43.99
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 3,496 $42.35
84100 <1% 1,696 $42.03
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,287 $39.66
82553 <1% 895 $39.59
A9270 Non-covered item or service <1% 92,438 $38.46
76937 <1% 106 $38.25
J1956 Injection, levofloxacin, 250 mg <1% 1,264 $29.65
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 2,317 $28.68
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,532 $26.13
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 5,181 $26.00
J2550 Injection, promethazine hcl, up to 50 mg <1% 607 $24.46
82010 <1% 509 $23.27
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 59 $22.05
84466 <1% 357 $19.71
J1790 Injection, droperidol, up to 5 mg <1% 193 $19.56
J1644 Injection, heparin sodium, per 1000 units <1% 3,436 $16.54
83540 <1% 359 $13.21
87210 <1% 291 $13.16
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 5,947 $12.29
85018 <1% 887 $12.23
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 505 $12.16
84132 <1% 2,401 $11.79
85652 <1% 947 $9.58
87081 <1% 185 $7.60
J3370 Injection, vancomycin hcl, 500 mg <1% 959 $7.48
85014 <1% 385 $5.68
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 601 $2.33
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 1,185 $0.00
80329 0% 656 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 312 $0.00
87205 0% 2,016 $0.00
J7999 Compounded drug, not otherwise classified 0% 754 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 202 $0.00
72040 0% 12 $0.00
87147 0% 47 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 522 $0.00
96368 0% 218 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 226 $0.00
87070 0% 1,659 $0.00
88304 0% 261 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 193 $0.00
12001 0% 53 $0.00
86769 0% 47 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 137 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 621 $0.00
82607 0% 209 $0.00
36415 Collection of venous blood by venipuncture 0% 537 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 14 $0.00
76801 0% 77 $0.00
J0456 Injection, azithromycin, 500 mg 0% 52 $0.00
G0008 Administration of influenza virus vaccine 0% 58 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 555 $0.00
72170 0% 16 $0.00
77063 Screening digital breast tomosynthesis, bilateral 0% 16 $0.00
97165 0% 245 $0.00
87116 0% 26 $0.00
A9585 Injection, gadobutrol, 0.1 ml 0% 100 $0.00
87206 0% 56 $0.00
73090 0% 15 $0.00
87807 0% 13 $0.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 0% 41 $0.00
90686 0% 68 $0.00
83615 0% 48 $0.00
86635 0% 105 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 117 $0.00
82330 0% 28 $0.00
72072 0% 13 $0.00
G0379 Direct admission of patient for hospital observation care 0% 13 $0.00
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 0% 47 $0.00
71101 0% 15 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 3,554 $0.00
87075 0% 114 $0.00
S0028 Injection, famotidine, 20 mg 0% 712 $0.00
93041 0% 17 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 51 $0.00
84295 0% 101 $0.00
99152 0% 169 $0.00
82140 0% 217 $0.00
C1729 Catheter, drainage 0% 937 $0.00
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg 0% 148 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 209 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 131 $0.00
94664 0% 218 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 16 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 493 $0.00
J0692 Injection, cefepime hydrochloride, 500 mg 0% 26 $0.00
89051 0% 308 $0.00
C1758 Catheter, ureteral 0% 168 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 20 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 129 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 135 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 96 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 65 $0.00
36600 0% 46 $0.00
P9016 Red blood cells, leukocytes reduced, each unit 0% 68 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 44 $0.00
87102 0% 32 $0.00
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 0% 24 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 0% 54 $0.00
88112 0% 29 $0.00
72141 0% 12 $0.00
73140 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHOLM, STAN (CEO)
Parent organizationBANNER HEALTH